Mulmit

Entera Bio Ltd.Entera Bio Ltd.

ENTX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3142,000-11,529,000-11,439,0000.25
2024-12-31181,000-9,585,000-9,541,0000.25
2023-12-310-8,891,000-8,889,0000.31
2022-12-31134,000-13,017,000-13,071,0000.45
2021-12-31571,000-12,217,000-12,187,0000.47

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-07Rubin Steven D19,117
2026-08-07Rubin Steven D33,368
2026-08-07Rubin Steven D43,405
2026-08-07Malca Yonatan22,815
2026-08-07Taitel Haya20,790
2026-08-07Ellis Sean20,034
2026-08-07Ellis Sean40,000
2026-08-07Yaacov-Garbeli DanaChief Financial Officer140,000
2026-08-07Galitzer HillelChief Operating Officer200,000
2026-08-07Burshtein GregoryChief of R&D180,000
2026-08-07Toledano Miranda JayneChief Executive Officer500,000
2026-08-07Toledano Miranda JayneChief Executive Officer200,000

8-K events

FiledItems
2026-08-18Regulation FD disclosure · Other events · Financial statements and exhibits
2026-08-07Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-07-28Entry into a material agreement · Unregistered sales of equity securities · Officer or director change · Financial statements and exhibits
2026-07-16Officer or director change · Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-05-08Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-04-03Entry into a material agreement · Unregistered sales of equity securities · Financial statements and exhibits
2026-03-27Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-03-04Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.